Correlation Between RYOHIN UNSPADR/1 and BioNTech

Can any of the company-specific risk be diversified away by investing in both RYOHIN UNSPADR/1 and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RYOHIN UNSPADR/1 and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RYOHIN UNSPADR1 and BioNTech SE, you can compare the effects of market volatilities on RYOHIN UNSPADR/1 and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RYOHIN UNSPADR/1 with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of RYOHIN UNSPADR/1 and BioNTech.

Diversification Opportunities for RYOHIN UNSPADR/1 and BioNTech

0.7

Correlation Coefficient

RYOHIN UNSPADR/1  BioNTech

Poor diversification

The 3 months correlation between RYOHIN and BioNTech is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding RYOHIN UNSPADR1 and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and RYOHIN UNSPADR/1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RYOHIN UNSPADR1 are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of RYOHIN UNSPADR/1 i.e., RYOHIN UNSPADR/1 and BioNTech go up and down completely randomly.

Pair Corralation between RYOHIN UNSPADR/1 and BioNTech

Assuming the 90 days trading horizon RYOHIN UNSPADR1 is expected to generate 0.69 times more return on investment than BioNTech. However, RYOHIN UNSPADR1 is 1.45 times less risky than BioNTech. It trades about 0.34 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.09 per unit of risk. If you would invest  1,800  in RYOHIN UNSPADR1 on October 22, 2024 and sell it today you would earn a total of  480.00  from holding RYOHIN UNSPADR1 or generate 26.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

RYOHIN UNSPADR1  vs.  BioNTech SE

RYOHIN UNSPADR/1

Risk-Adjusted Performance

29 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in RYOHIN UNSPADR1 are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain forward-looking signals, RYOHIN UNSPADR/1 reported solid returns over the last few months and may actually be approaching a breakup point.

BioNTech SE

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioNTech reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with RYOHIN UNSPADR/1 and BioNTech

The main advantage of trading using opposite RYOHIN UNSPADR/1 and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RYOHIN UNSPADR/1 position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind RYOHIN UNSPADR1 and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.